Events posted are for the biosafety community and are not automatically approved for CM Points.
Approved trainings can be found here.

Have an event? List it in the Biosafety Calendar.
Events submitted must be approved and may take up to 3 business days to appear on the website.
If you login first you will be able to modify your calendar events if you need to.

Webinar

  1. Events
  2. Venues
  3. Webinar
Events at this venue
Today

11. Field Biosafety: Protecting Researchers and Communities in Wildlife Disease Investigations

Webinar

This webinar will provide comprehensive training on field biosafety, designed specifically for biosafety professionals, researchers, veterinarians, and field personnel involved in wildlife disease research. The course is structured to offer practical guidance on assessing biosafety risks in diverse field settings and effectively implementing the Field Biosafety Levels (FBSLs)—a structured framework for zoonotic disease protection. Participants will learn to critically evaluate risks, determine appropriate biosafety levels, and apply best practices in real-world scenarios. Over the two sessions, participants will be introduced to key principles of field biosafety and detailed considerations for advising researchers on potential risks. Participants will also explore the practical application of Field Biosafety Levels (FBSLs) as a proposed standardized approach to managing zoonotic risks in diverse field environments. In the final session, participants will be given a brief recap, followed by an interactive implementation practice exercise. Real-world examples, including visual aids illustrating proper and improper biosafety practices, will be reviewed. Participants will engage in active discussions, analyzing images to identify potential biosafety hazards and propose solutions. The webinar concludes with an open Q&A session.

06. Large-scale Biosafety

Webinar

Large-scale Biosafety will review biosafety for work at large-scale, which the NIH rDNA Guidelines defines as >10L. The course will review Appendix K from GLSP to BSL-3 LS, with a focus on primary and secondary containment. It will review basic bioprocessing steps, such as fermentation/cell culture and purification technologies. Examples of classic and newer single use technologies will be provided. Pearls and pitfalls of the various technologies will be discussed, using various scenarios. The course will include a review of risk assessment techniques used for large scale bioprocesses and a discussion of large-scale related to vaccines, viral vectors, and recombinant proteins.

07. Molecular Biology 101

Webinar

Molecular Biology 101 is intended for those professionals that participate in protocol review, facilities planning, and other risk assessment activities but lack a basic understanding of molecular biology and techniques. Following this course, attendees will be able to do more than regurgitate facts and use the new understanding of the principles of molecular biology in various situations at their institution. This course will cover topics such as the chemistry of nucleic acids, DNA replication, RNA transcription, and protein translation, the Central Dogma of Biology, DNA cloning, transfection of prokaryotic and eukaryotic cells, restriction enzymes, and recombinant DNA lab methodologies (including PCR, DNA fingerprinting, sequencing, and detection protocols). While this course will not turn you into a molecular biologist, it will give you enough background information to understand the nature and manipulation of genetic material and hopefully unveil the mystery of deoxyribonucleic acid.

12. Laboratories & 1st Responders: Coordination, Planning, & Emergency Response

Webinar

Laboratories & 1st Responders: Coordination, Planning, & Emergency Response webinar will provide researchers, administrators, and safety professionals working in laboratory facilities with recommendations and best practices on how to establish beneficial working relationships with regional emergency response agencies. This webinar will provide an overview of emergency management functions, strategies for engaging 1st responders, recommendations on how to prepare research facilities for emergencies, and breakout sessions and case studies to discuss how to build relationships, support 1st responders, develop response procedures, and conduct exercise planning. Ample time will be provided throughout the webinar to discuss participant experiences and concerns.

08. Virus-based Gene Transfer Vectors

Webinar

Virus-based Gene Transfer Vectors is an intermediate course that will examine the molecules, processes, and techniques involved in recombinant gene expression. Participants will explore the technology of how viruses are converted into vector systems for the transfer of gene expression constructs. Common viral vector systems, including retroviruses, lentiviruses, adenoviruses, poxviruses, herpesviruses, alphaviruses, and baculoviruses will be discussed with an emphasis on the biosafety characteristics of the vectors derived from these viruses. This course is targeted for the biosafety professional who is not actively conducting laboratory research yet requires a basic understanding of recombinant DNA methodology.

09. Introduction to Biosafety in the Clinical Setting

Webinar

The clinical setting poses a different environment than research laboratories. This course provides foundations for applying biosafety concepts in the clinical setting. Course topics include common issues and lessons learned pertaining to clinical facilities including pharmacies, laboratories, clinics, infusion areas, ORs, and waste disposal facilities; PPE, disinfection, risk assessments, and safety practices in the clinical setting; speaking biosafety to doctors, nursing staff, pharmacy staff, infection prevention and control, diagnostic microbiology lab personnel, and hospital EHS staff; applying NIH Guidelines and the BMBL to the clinical setting; gaps in oversight of research safety for clinical trials, and risk assessments for unconventional or highly specialized delivery mechanisms for biologics. The course will conclude with a focus on clinical trials including the role of an IRB and how it can overlap with an IBC; the process for investigational products to obtain FDA approval to be deemed as safe and effective therapeutics; and the evolving regulatory environment in the U.S. for biologics such as vaccines, regenerative medicines, and gene therapy. The course is designed to be highly interactive with discussions, surveys, and group exercises.

Go to Top